Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Recurrent Non-Small Cell Lung Cancer Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, visits or treatment by using a genuine doctor. We aren't physicians. Always confer with your physician about Recurrent Non-Small Cell Lung Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Recurrent Non-Small Cell Lung Cancer Clinical research trials and Recurrent Non-Small Cell Lung Cancer medical trials occur in hundreds of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually assess the effectiveness of new does drugs. The purpose of the studies / projects is to answer particular human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all sorts of conditions, such as Recurrent Non-Small Cell Lung Cancer. Recurrent Non-Small Cell Lung Cancer Clinical Trials and other clinical trials allow for volunteers to access healthcare treatment choices before they are available to the general public. Many times the participants receive treatment for free, and occasionally they are paid for their time. Occasionally there is a cost for a Recurrent Non-Small Cell Lung Cancer clinical trial. Subjects frequently receive the best healthcare available for their Recurrent Non-Small Cell Lung Cancer affliction. Risks are a reality, nevertheless, and might include extra or frequent physician visits, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > Clinical Trials by Conditions > "R" Clinical Trial Conditions > Recurrent Non-Small Cell Lung Cancer Clinical Trials

Recurrent Non-Small Cell Lung Cancer Clinical Trials



10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
Condition: eortc_lung_cancer_cooperative_group_clinical_trials.html
EORTC Lung Cancer Cooperative Group

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: university_of_texas_clinical_trials.html
University of Texas

Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Condition: california_cancer_consortium_clinical_trials.html
California Cancer Consortium

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer
Condition: university_of_wisconsin_comprehensive_cancer_center_clinical_trials.html
University of Wisconsin Comprehensive Cancer Center

Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
Condition: north_central_cancer_treatment_group_clinical_trials.html
North Central Cancer Treatment Group

Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: barbara_ann_karmanos_cancer_institute_clinical_trials.html
Barbara Ann Karmanos Cancer Institute

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: sanofisynthelabo_clinical_trials.html
Sanofi-Synthelabo

Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: robert_h_lurie_cancer_center_clinical_trials.html
Robert H. Lurie Cancer Center

Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Condition: istituto_nazionale_per_la_ricerca_sul_cancro_clinical_trials.html
Istituto Nazionale per la Ricerca sul Cancro

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: eastern_cooperative_oncology_group_clinical_trials.html
Eastern Cooperative Oncology Group

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
Condition: eastern_cooperative_oncology_group_clinical_trials.html
Eastern Cooperative Oncology Group

Combination Chemotherapy With or Without Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: genentech_clinical_trials.html
Genentech

Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Condition: istituto_nazionale_per_lo_studio_e_la_cura_dei_tumori_clinical_trials.html
Istituto Nazionale per lo Studio e la Cura dei Tumori

Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
Condition: genta_clinical_trials.html
Genta

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
Condition: rush_cancer_institute_at_rush_university_medical_center_clinical_trials.html
Rush Cancer Institute at Rush University Medical Center

Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Condition: barbara_ann_karmanos_cancer_institute_clinical_trials.html
Barbara Ann Karmanos Cancer Institute

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Gemcitabine, Carboplatin, and Bortezomib in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Condition: eastern_cooperative_oncology_group_clinical_trials.html
Eastern Cooperative Oncology Group

Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small cell Lung Cancer
Condition: eortc_early_clinical_studies_group_clinical_trials.html
EORTC Early Clinical Studies Group

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
Condition: ottawa_regional_cancer_centre_clinical_trials.html
Ottawa Regional Cancer Centre

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer
Condition: neurocrine_biosciences_clinical_trials.html
Neurocrine Biosciences

Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Unresectable Brain Metastases From Non-Small Cell Lung Cancer
Condition: norris_cotton_cancer_center_clinical_trials.html
Norris Cotton Cancer Center

Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
Condition: cancer_and_leukemia_group_b_clinical_trials.html
Cancer and Leukemia Group B

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: tularik_clinical_trials.html
Tularik

Lonafarnib and Gemcitabine in Treating Patients With Advanced Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group

Monoclonal Antibody Plus Carboplatin and Paclitaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Paclitaxel in Treating Patients With Lung Cancer
Condition: eortc_lung_cancer_cooperative_group_clinical_trials.html
EORTC Lung Cancer Cooperative Group

Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase I/II Study of Cetuximab, Gemcitabine, and Carboplatin in Patients With Chemotherapy-Naive Stage IV Non-Small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)



Recurrent Non-Small Cell Lung Cancer Clinical Trials

Modify your Search

Recurrent Non-Small Cell Lung Cancer Clinical Trials by State:

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin

Other "R" Clinical Trials Conditions:

Radiation Enteritis
Radiation Fibrosis
Radiation Injuries
Radiation Toxicity
Radiculitis
Radiculopathy
Raman Spectroscopy
Rapid Cycling Bipolar Disorder
Raynaud Disease
Raynaud's Disease
Rectal Cancer
Rectal Neoplasms
Recurrence
Recurrent Abdominal Pain
Recurrent Adenoid Cystic Carcinoma Of The Oral Cavity
Recurrent Adrenocortical Carcinoma
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Acute Lymphocytic Leukemia
Recurrent Adult Acute Myeloid Leukemia
Recurrent Adult Brain Tumor
Recurrent Adult Burkitt's Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Recurrent Adult Diffuse Small Noncleaved Cell/burkitt's Lymphoma
Recurrent Adult Hodgkin's Disease
Recurrent Adult Hodgkin's Lymphoma
Recurrent Adult Immunoblastic Large Cell Lymphoma
Recurrent Adult Lymphoblastic Lymphoma
Recurrent Adult Non-Hodgkin's Lymphoma
Recurrent Adult Primary Liver Cancer
Recurrent Adult Soft Tissue Sarcoma
Recurrent Adult T-Cell Leukemia/lymphoma
Recurrent Angiocentric Immunoproliferative Lesions
Recurrent Bladder Cancer
Recurrent Brain Tumor
Recurrent Breast Cancer
Recurrent Carcinoma Of Unknown Primary
Recurrent Cervical Cancer
Recurrent Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Myeloid Leukemia
Recurrent Childhood Brain Stem Glioma
Recurrent Childhood Brain Tumor
Recurrent Childhood Cerebellar Astrocytoma
Recurrent Childhood Cerebral Astrocytoma
Recurrent Childhood Ependymoma
Recurrent Childhood Hodgkin's Disease
Recurrent Childhood Large Cell Lymphoma
Recurrent Childhood Liver Cancer
Recurrent Childhood Lymphoblastic Lymphoma
Recurrent Childhood Malignant Germ Cell Tumor
Recurrent Childhood Medulloblastoma
Recurrent Childhood Rhabdomyosarcoma
Recurrent Childhood Small Noncleaved Cell Lymphoma
Recurrent Childhood Soft Tissue Sarcoma
Recurrent Childhood Supratentorial Primitive Neuroectodermal And Pineal Tumors
Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumors
Recurrent Childhood Visual Pathway Glioma
Recurrent Colon Cancer
Recurrent Cutaneous T-Cell Lymphoma
Recurrent Diffuse Small Lymphocytic/marginal Zone Lymphoma
Recurrent Endometrial Cancer
Recurrent Esophageal Cancer
Recurrent Extrahepatic Bile Duct Cancer
Recurrent Gallbladder Cancer
Recurrent Gastric Cancer
Recurrent Gastrointestinal Carcinoid Tumor
Recurrent Gestational Trophoblastic Tumor
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Recurrent Grade I Follicular Small Cleaved Cell Lymphoma
Recurrent Grade Ii Follicular Mixed Cell Lymphoma
Recurrent Grade Iii Follicular Large Cell Lymphoma
Recurrent Intraocular Melanoma
Recurrent Kaposi's Sarcoma
Recurrent Malignant Mesothelioma
Recurrent Malignant Thymoma
Recurrent Mantle Cell Lymphoma
Recurrent Melanoma
Recurrent Merkel Cell Carcinoma
Recurrent Metastatic Squamous Neck Cancer With Occult Primary
Recurrent Mycosis Fungoides/sezary Syndrome
Recurrent Neuroblastoma
Recurrent Non-Small Cell Lung Cancer
Recurrent Osteosarcoma
Recurrent Ovarian Epithelial Cancer
Recurrent Ovarian Germ Cell Tumor
Recurrent Pancreatic Cancer
Recurrent Peripheral Primitive Neuroectodermal Tumor
Recurrent Prostate Cancer
Recurrent Rectal Cancer
Recurrent Renal Cell Cancer
Recurrent Respiratory Papillomatosis
Recurrent Retinoblastoma
Recurrent Salivary Gland Cancer
Recurrent Skin Cancer
Recurrent Small Cell Lung Cancer
Recurrent Small Intestine Cancer
Recurrent Small Lymphocytic Lymphoma
Recurrent Squamous Cell Carcinoma Of The Hypopharynx
Recurrent Squamous Cell Carcinoma Of The Larynx
Recurrent Squamous Cell Carcinoma Of The Lip And Oral Cavity
Recurrent Squamous Cell Carcinoma Of The Nasopharynx
Recurrent Squamous Cell Carcinoma Of The Oropharynx
Recurrent Squamous Cell Carcinoma Of The Paranasal Sinus And Nasal Cavity
Recurrent Testicular Cancer
Recurrent Thymoma And Thymic Carcinoma
Recurrent Thyroid Cancer
Recurrent Transitional Cell Cancer Of The Renal Pelvis And Ureter
Recurrent Tumors Of The Ewing's Family
Recurrent Urethral Cancer
Recurrent Uterine Sarcoma
Recurrent Vulvar Cancer
Recurrent Wilms' Tumor And Other Childhood Kidney Tumors
Recurrent/refractory Childhood Hodgkin's Disease
Recurrent/refractory Childhood Hodgkin's Lymphoma
Red-Cell Aplasia, Pure
Reduction Of Total Body Iron Storage(tbis)
Reflex Sympathetic Dystrophy
Refractive Error
Refractory Anemia
Refractory Anemia With Excess Blasts
Refractory Anemia With Excess Blasts In Transformation
Refractory Anemia With Ringed Sideroblasts
Refractory Chronic Lymphocytic Leukemia
Refractory Chronic Myelogenous Leukemia
Refractory Cytopenia
Refractory Hairy Cell Leukemia
Refractory Lymphoma
Refractory Plasma Cell Neoplasm
Regional Gastrointestinal Carcinoid Tumor
Regional Neuroblastoma
Regional Transitional Cell Cancer Of The Renal Pelvis And Ureter
Rehabilitation
Reiter's Disease
Relapsed Lymphoma
Relapsing Chronic Myelogenous Leukemia
Relapsing-Remitting Multiple Sclerosis
Renal Allograft Recipients
Renal Anemia
Renal Artery Obstruction
Renal Cancer
Renal Cell Adenocarcinoma
Renal Cell Cancer
Renal Cell Carcinoma
Renal Clear Cell Carcinoma
Renal Failure
Renal Granular Cell Carcinoma
Renal Insufficiency, Chronic
Renal Neoplasm
Renal Osteodystrophy
Renal Transplant Recipients
Renovascular Hypertension
Reproductive Cancer
Reproductive Cancers
Respiration Disorders
Respiratory Acidosis
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Respiratory Papillomas
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus Infections
Respiratory Tract Diseases
Rest Leg Pain
Restless Legs Syndrome
Retinal Degeneration
Retinal Detachment
Retinal Disease
Retinal Diseases
Retinal Hemangioblastoma
Retinal Neovascularization
Retinal Vasculitis
Retinal Vein Occlusion
Retinitis
Retinitis Pigmentosa
Retinoblastoma
Retinopathy Of Prematurity
Retinoschisis
Retroviridae Infections
Rett Syndrome
Rhabdoid Tumor Of The Kidney
Rhabdomyosarcoma
Rheumatic Disease
Rheumatic Diseases
Rheumatoid Arthritis
Rhinitis
Rhinitis, Allergic, Nonseasonal
Rhinitis, Allergic, Seasonal
Rickets


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103